BrightSpring Health Services, Inc. Common Stock
HealthcareNASDAQ:BTSG · NASDAQ Global Select
-$0.54 today
Vol 3.90M · Avg 2.97M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$13.6B of revenue converted into $235.6M of net income for the selected period. Gross margin is 12.2% and net margin is 1.7%, showing how much revenue survives after costs and taxes. EPS is $1.41, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9B +14.6% | $11.3B +27.6% | $8.8B +14.3% | $7.7B +15.3% | $6.7B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $11.4B +17.7% | $9.7B +30.9% | $7.4B +16.1% | $6.4B +16.8% | $5.4B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.5B -4.4% | $1.6B +10.8% | $1.4B +5.9% | $1.4B +8.5% | $1.2B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 11.8% -2.3pp | 14.1% -2.1pp | 16.2% -1.3pp | 17.5% -1.1pp | 18.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.1B -19.7% | $1.4B +7.4% | $1.3B +14.3% | $1.1B +11.0% | $1.0B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.1B -19.7% | $1.4B +7.4% | $1.3B +10.3% | $1.2B +15.0% | $1.0B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $164.3M -19.7% | $204.5M +1.1% | $202.3M -0.8% | $204.0M +2.4% | $199.2M | $374.2M | $1.2B | $631.8M |
| EBITDA | $572.3M +43.8% | $398.1M +13.9% | $349.5M -10.8% | $391.8M -9.6% | $433.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 4.4% +0.9pp | 3.5% -0.4pp | 4.0% -1.1pp | 5.1% -1.4pp | 6.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $408.1M +97.7% | $206.4M +40.2% | $147.2M -21.6% | $187.8M -19.8% | $234.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 3.2% +1.3pp | 1.8% +0.2pp | 1.7% -0.8pp | 2.4% -1.1pp | 3.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $157.3M -31.1% | $228.4M -29.6% | $324.6M +39.0% | $233.6M +41.3% | $165.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$270.1M -12.0% | -$241.1M +25.7% | -$324.6M -39.0% | -$233.6M -41.3% | -$165.3M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $137.9M +497.1% | -$34.7M +80.4% | -$177.4M -287.8% | -$45.8M -166.4% | $68.9M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 1.1% +1.4pp | -0.3% +1.7pp | -2.0% -1.4pp | -0.6% -1.6pp | 1.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $33.1M +333.1% | -$14.2M +30.9% | -$20.6M -343.1% | $8.5M -51.9% | $17.6M | $1.3B | -$1.6B | $745.2M |
| Net Income | $190.7M +1155.6% | -$18.1M +88.3% | -$154.6M -186.8% | -$53.9M -208.2% | $49.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 1.5% +1.6pp | -0.2% +1.6pp | -1.8% -1.1pp | -0.7% -1.4pp | 0.7% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 +1104.3% | -$0 +89.6% | -$1 -190.3% | -$0 -206.9% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 +1029.5% | -$0 +89.6% | -$1 -190.3% | -$0 -206.9% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $202.6M +5.0% | $193.0M +12.7% | $171.2M +0.0% | $171.2M +0.0% | $171.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $219.8M +13.9% | $193.0M +12.7% | $171.2M +0.0% | $171.2M +0.0% | $171.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Krystal Biotech, Inc.
NASDAQ:KRYS
$9.38B
Bruker Corporation
NASDAQ:BRKR
$8.19B
HealthEquity, Inc.
NASDAQ:HQY
$7.37B
Teleflex Incorporated
NYSE:TFX
$5.79B
Chemed Corporation
NYSE:CHE
$5.58B
CRISPR Therapeutics AG
NASDAQ:CRSP
$4.82B
Stevanato Group S.p.A.
NYSE:STVN
$4.66B
RadNet, Inc.
NASDAQ:RDNT
$4.50B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$3.95B
iRhythm Technologies, Inc.
NASDAQ:IRTC
$3.70B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does BTSG generate?
BrightSpring Health Services, Inc. Common Stock (BTSG) reported $12.91B of revenue in fiscal 2025.
Is BTSG profitable?
BrightSpring Health Services, Inc. Common Stock (BTSG) reported $190.67M of net income, with a net margin of 1.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.